Novartis to Investigate Second Death in Gene Therapy Trials

April 29, 2019

Despite positive interim trial results for its experimental gene therapy for spinal muscular atrophy in infants, Novartis AG announced last week it will investigate a second trial death that may be related to the same treatment.

WCG Welcomes Applicants for New Global Research Network

March 25, 2019

WIRB-Copernicus Group (WCG) is inviting clinical researchers to apply for membership in its Global Research Network (GRN), a free service that offers networking opportunities, trial insights and sponsor connections.